全文获取类型
收费全文 | 28370篇 |
免费 | 1555篇 |
国内免费 | 262篇 |
专业分类
耳鼻咽喉 | 253篇 |
儿科学 | 550篇 |
妇产科学 | 600篇 |
基础医学 | 2919篇 |
口腔科学 | 673篇 |
临床医学 | 2010篇 |
内科学 | 8171篇 |
皮肤病学 | 361篇 |
神经病学 | 2415篇 |
特种医学 | 1085篇 |
外科学 | 5229篇 |
综合类 | 54篇 |
一般理论 | 5篇 |
预防医学 | 1125篇 |
眼科学 | 531篇 |
药学 | 1667篇 |
中国医学 | 57篇 |
肿瘤学 | 2482篇 |
出版年
2024年 | 32篇 |
2023年 | 291篇 |
2022年 | 609篇 |
2021年 | 1033篇 |
2020年 | 591篇 |
2019年 | 846篇 |
2018年 | 1006篇 |
2017年 | 731篇 |
2016年 | 882篇 |
2015年 | 905篇 |
2014年 | 1226篇 |
2013年 | 1511篇 |
2012年 | 2300篇 |
2011年 | 2185篇 |
2010年 | 1255篇 |
2009年 | 1208篇 |
2008年 | 1892篇 |
2007年 | 1829篇 |
2006年 | 1727篇 |
2005年 | 1717篇 |
2004年 | 1611篇 |
2003年 | 1374篇 |
2002年 | 1245篇 |
2001年 | 142篇 |
2000年 | 137篇 |
1999年 | 180篇 |
1998年 | 212篇 |
1997年 | 167篇 |
1996年 | 158篇 |
1995年 | 154篇 |
1994年 | 127篇 |
1993年 | 117篇 |
1992年 | 100篇 |
1991年 | 59篇 |
1990年 | 69篇 |
1989年 | 55篇 |
1988年 | 42篇 |
1987年 | 37篇 |
1986年 | 45篇 |
1985年 | 42篇 |
1984年 | 36篇 |
1983年 | 34篇 |
1982年 | 49篇 |
1981年 | 30篇 |
1980年 | 27篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1976年 | 12篇 |
1975年 | 10篇 |
1974年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Roberto Grimaldi Marta Bisi Enrica Lonni Eloise Beggiato Alessandra Valpreda Marco Francesco Lococo Enrico Dosio Davide Giacomo Presutti Milena Tagliabue Fiorenzo Gaita 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2014,28(4):323-329
Purpose
Aspirin resistance occurs most frequently in diabetic patients and is associated with poor prognosis. The purpose of this study was to evaluate the prevalence of aspirin resistance in a cohort of diabetic patients and whether it can be reversed using more bioavailable aspirin formulations.Methods
Platelets function of 163 diabetic patients taking acetyl salicylic acid (ASA) 100 mg daily has been evaluated with PFA100 and VerifyNow. Patients found resistant by at least one test received an infusion of 288 mg of lysine acetylsalicylate (Flectadol®) corresponding to ASA 160 mg. Platelets function was measured again after 1 and 24 h. Patients whose the resistance was reversed received 288 mg of soluble salt of lysine acetylsalicylate (Cardirene 160®) corresponding to ASA160 mg instead of aspirin and their aggregation status was re-evaluated after 1 month of therapy.Results
Prevalence of aspirin resistance in our population was 18,4 % (30/163). In 27 out of 30 patients (90 %) aspirin resistance was reversed within 24 h from the infusion. 25 out of 27 patients (92 %) were found fully aspirin-sensitive after 1 month of oral therapy with soluble salt; two patients were found with borderline value. No adverse reactions were observed.Conclusions
A significant number of diabetic patients are resistant to aspirin therapy. A single intravenous dose of lysine acetylsalicylate can reverse the platelet hyper-aggregability and laboratory aspirin resistance in large majority of patients. The efficacy of antiaggregation can be maintained by chronic therapy with an oral drug with a more favourable pharmacokinetic profile. 相似文献992.
Caterina Tatarelli Anna Lina Piccioni Luca Maurillo Virginia Naso Roberta Battistini Mariella D’Andrea Marianna Criscuolo Carolina Nobile Nicoletta Villivà Stefano Mancini Benedetta Neri Massimo Breccia Susanna Fenu Francesco Buccisano Maria Teresa Voso Roberto Latagliata Maria Antonietta Aloe Spiriti 《Annals of hematology》2014,93(8):1413-1420
Myelodysplastic syndromes (MDS) are common in elderly patients. Recombinant human erythro-poietin (rHuEPO) has been widely used to treat anemia in lower risk MDS patients, but few data are known about rHuEPO treatment in the very elderly patient group. In order to investigate the role of rHuEPO treatment in terms of response, overall survival (OS), and toxicity in a very elderly MDS patient group, 93 MDS patients treated with rHuEPO when aged ≥80 years were selected among MDS cases enrolled in a retrospective multicenter study by the cooperative group Gruppo Romano Mielodisplasie (GROM) from Jan 2002 to Dec 2010. At baseline, median age was 82.7 (range 80–99.1) with a median hemoglobin (Hb) level of 9 g/dl (range 6–10.8). The initial dose of rHuEPO was standard (epoetin alpha 40,000 IU/week or epoetin beta 30,000 IU/week) in 59 (63.4 %) pa-tients or high in 34 (36.6 %) (epoetin alpha 80,000 IU/week) patients. We observed an erythroid response (ER) in 59 (63.4 %) patients. No thrombotic event was reported. Independent predictive factors for ER were low transfusion requirement before treatment (p?=?0.004), ferritin <200 ng/ml (p?=?0.017), Hb >8 g/dl (p?=?0.034), and a high-dose rHuEPO treatment (p?=?0.032). Median OS from rHuEPO start was 49.3 months (95 % CI 27.5–68.4) in responders versus 30.6 months (95 % CI 7.3–53.8) in resistant patients (p?=?0.185). In conclusion, rHuEPO treatment is safe and effective also in the very elderly MDS patients. However, further larger studies are warranted to evaluate if EPO treatment could be worthwhile in terms of quality of life and cost-efficacy in very old patients. 相似文献
993.
994.
Francesco Rotella Ilaria Dicembrini Lisa Lazzeretti Michela Bigiarini Valdo Ricca Carlo Maria Rotella Edoardo Mannucci 《Acta diabetologica》2014,51(1):133-140
Many psychiatric disorders and symptoms have been associated with impaired metabolic control in type 2 diabetes; several studies focused on non-pathological psychological features. Aims of this observational, longitudinal study are: the assessment of the impact of a wide range of psychological factors on metabolic control in type 2 diabetes; and the development and validation of a simple questionnaire to assess the impact of psychological factors on therapeutic success. To identify psychological factors interfering with attainment of glycemic targets, a prospective 1-year study was performed on a sample of 250 patients with type 2 diabetes. The impact of identified factors on therapeutic outcome was then subsequently verified on a further, independent sample of 200 patients. The first phase of the study allowed the development of a 19-items questionnaire, the Psychological Predictors of Therapeutic success in Diabetes (PPTD) questionnaire. Validation analyses showed that the questionnaire was able to predict therapeutic success. Patients with HbA1c ≤7 % (53 mmol/mol) at follow-up showed higher test scores than those with HbA1c >7 % [31.0 (26.2; 35.0) vs 28.0 (23.0; 32.0); p = 0.016]. The attainment and maintenance of therapeutic goals in patients with type 2 diabetes depend on a wide range of factors. The PPTD is an attempt at condensing the complexity of psychological factors affecting glycemic control in a simple and easy-to-use self-reported questionnaire, which can be used in wide-scale research. 相似文献
995.
Giovanni Gulli Stefania Frasson Vito Borzì Andrea Fontanella Marco Grandi Claudio Marengo Antonio Nicolucci Ruggero Pastorelli Bruno Solerte Adriano Gatti Francesco Cristiano Raimondo Erminio Bonizzoni Gualberto Gussoni Antonino Mazzone Antonio Ceriello 《Acta diabetologica》2014,51(5):765-770
Appropriate management of hyperglycemia is crucial for patients with type 2 diabetes. Aim of the FADOI-DIAMOND study was to evaluate real-world management of type 2 diabetic patients hospitalized in Internal Medicine wards (IMW) and the effects of a standardized educational intervention for IMW staff. DIAMOND has been carried out in 53 Italian IMW, with two cross-sectional surveys interspersed with an educational program (PRE phase and POST phase). In PRE phase, each center reviewed the charts of the last 30 hospitalized patients with known type 2 diabetes. An educational program was conducted in each center by means of the “outreach visit,” a face-to-face meeting between IMW staff and a trained external expert. Six months after, each center repeated the data collection (POST phase), specular to the PRE. A total of 3,167 patients were enrolled (1,588 PRE and 1,579 POST). From PRE phase to POST, patients with registered anthropometric data (54.1 vs. 74.9 %, p < 0.001) and in-hospital/recent measurement of glycated hemoglobin (48.2 vs. 61.4 %, p < 0.005) increased significantly. After educational program, more patients received insulin during hospitalization (68.3 vs. 63.6 %, p = 0.005). A more relevant variation in glycemia during hospitalization was observed in POST phase than PRE (?22.2 vs. ?15.5 mg/dL, p < 0.001), without differences as for occurrence of hypoglycemia (12.3 vs. 11.9 %). A one-shot educational intervention led to persistent improvement in the management of hospitalized patients with type 2 diabetes and to significant better glycemic control. Further studies might evaluate the effectiveness of a more aggressive educational program, on both management and outcomes. 相似文献
996.
Shalender Bhasin MB BS Thomas G. Travison PhD Todd M. Manini PhD Sheena Patel MS Karol M. Pencina PhD Roger A. Fielding PhD Jay M. Magaziner PhD Anne B. Newman MD MPH Douglas P. Kiel MD Cyrus Cooper DM FMedSci Jack M. Guralnik MD PhD Jane A. Cauley Dr.PH Hidenori Arai MD PhD Brian C. Clark PhD Francesco Landi MD PhD Laura A. Schaap PhD Suzette L. Pereira PhD Daniel Rooks PhD Jean Woo MD PhD Linda J. Woodhouse PhD Ellen Binder MD Todd Brown MD Michelle Shardell PhD Quian-Li Xue PhD Ralph B. DʼAgostino Sr PhD Denise Orwig PhD Greg Gorsicki PhD Rosaly Correa-De-Araujo MD PhD Peggy M. Cawthon PhD 《Journal of the American Geriatrics Society》2020,68(7):1410-1418
997.
Fabio InfusinoGiampaolo Niccoli MD PhD Francesco FracassiMarco Roberto MD Elena FalcioniGaetano A. Lanza MD Filippo Crea MD 《Journal of electrocardiology》2014
Guidelines report that the optimal treatment for ST-elevation myocardial infarction (STEMI) is a primary percutaneous coronary intervention (PPCI) when performed timely by trained operators. Yet, the reopening of the infarct-related artery (IRA) is not always followed by myocardial reperfusion. This phenomenon is most commonly called “no-reflow”, is caused by microvascular obstruction (MVO) and is associated to a worse outcome. Electrocardiogram (ECG) is crucial for the diagnosis of STEMI, but is also useful for the assessment of MVO. In this review we summarize ECG-derived parameters associated to MVO and their prognostic relevance. 相似文献
998.
999.
1000.
Frédéric Baron Fabio Efficace Laura Cannella Petra Muus Silvia Trisolini Constantijn J. M. Halkes Paola Fazi Marco Vignetti Jean-Pierre Marie Patrizia Chiusolo Walter van der Velden Edoardo La Sala Umberto Vitolo Xavier Thomas Francois Lefrère Sr. Francesco Di Raimondo Jean-Henri Bourhis Giorgina Specchia José E. Guimarães Bernardino Allione Radovan Vrhovac Felicetto Ferrara Marian Stevens-Kroef Liv Meert Theo de Witte Roelof Willemze Sergio Amadori Stefan Suciu 《American journal of hematology》2020,95(7):749-758
We provide a long-term evaluation of patients enrolled in the EORTC/GIMEMA AML-10 trial which included a total of 2157 patients, 15-60 years old, randomized to receive either daunorubicin (DNR, 50 mg/m2), mitoxantrone (MXR, 12 mg/m2), or idarubicin (IDA, 10 mg/m2) in addition to standard-dose cytarabine and etoposide for induction chemotherapy and intermediate dose cytarabine for consolidation. Younger patients who reached complete remission with complete (CR) or incomplete (CRi) recovery were then scheduled to receive an allogeneic hematopoietic stem cell transplantation (HSCT). That was if they had a HLA-identical sibling donor; in all other cases, an autologous HSCT had to be administered. At an 11-year median follow-up, the 5-year, 10-year and 15-year overall survival (OS) rates were 33.2%, 30.1% and 28.0%, respectively. No significant difference between the three randomized groups regarding OS was observed (P = .38). In young patients, 15-45 years old, no treatment difference (P = .89) regarding OS was observed, while in patients 46-60 years old, MXR and IDA groups had a trend for a longer OS as compared to the DNR group (P = .029). Among younger patients without a favorable MRC cytogenetic risk subgroup who achieved a CR/CRi after induction chemotherapy, those with a HLA-identical sibling donor had higher 10-year and 15-year OS rates than those without. In older patients who reached CR/CRi, the long-term outcomes of those with or without a donor was similar. In conclusion, long-term outcomes of the study confirmed similar OS in the three randomized groups in the whole cohort of patients. 相似文献